Lawsuit concerns Teva's application for approval to market Levitra for the treatment of erectile dysfunction
Multaq to treat patients with atrial fibrillation or atrial flutter
Calls for shutdown of a number of manufacturing assets, including ethylene and ethylene-derivative assets
Myriad Genetics to claim approximately $400 million in tax deductions
Business comprises a portfolio of 13 branded pharmaceuticals
Acorda to continue developing and commercializing Fampridine-SR in the US
